Mixed fortunes in the treatment of Crohn's disease

Lancet. 2012 Jun 9;379(9832):2212. doi: 10.1016/S0140-6736(12)60359-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Azathioprine / adverse effects
  • Crohn Disease / therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Leukemia, Lymphocytic, Chronic, B-Cell / chemically induced
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Middle Aged
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Azathioprine